Jpmorgan Chase & Co (JPM) Stock Value Declined While Sirios Capital Management LP Cut Holding; Aldeyra Therapeutics (ALDX) Shareholder 683 Capital Management Increased Holding

February 15, 2018 - By Henry Gaston

683 Capital Management Llc increased its stake in Aldeyra Therapeutics Inc (ALDX) by 59.12% based on its latest 2017Q3 regulatory filing with the SEC. 683 Capital Management Llc bought 310,421 shares as the company’s stock declined 12.75% while stock markets rallied. The hedge fund held 835,514 shares of the health care company at the end of 2017Q3, valued at $6.02 million, up from 525,093 at the end of the previous reported quarter. 683 Capital Management Llc who had been investing in Aldeyra Therapeutics Inc for a number of months, seems to be bullish on the $135.74 million market cap company. The stock increased 1.43% or $0.1 during the last trading session, reaching $7.1. About 93,165 shares traded. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has declined 18.94% since February 15, 2017 and is downtrending. It has underperformed by 35.64% the S&P500.

John Brennan decreased its stake in Jpmorgan Chase & Co (JPM) by 56% based on its latest 2017Q3 regulatory filing with the SEC. Sirios Capital Management LP sold 644,721 shares as the company’s stock declined 6.04% while stock markets rallied. The hedge fund run by John Brennan held 506,482 shares of the major banks company at the end of 2017Q3, valued at $48.37M, down from 1.15M at the end of the previous reported quarter. Sirios Capital Management LP who had been investing in Jpmorgan Chase & Co for a number of months, seems to be less bullish one the $393.96B market cap company. The stock increased 2.31% or $2.6 during the last trading session, reaching $115.03. About 15.19M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since February 15, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. JPMorgan Chase & Co had 110 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Neutral” rating by UBS on Friday, January 15. Citigroup maintained the stock with “Neutral” rating in Friday, October 6 report. Jefferies maintained it with “Buy” rating and $78 target in Tuesday, July 21 report. The stock has “Neutral” rating by Robert W. Baird on Wednesday, November 9. The stock has “Hold” rating by Keefe Bruyette & Woods on Friday, August 18. Vetr downgraded JPMorgan Chase & Co. (NYSE:JPM) on Friday, August 28 to “Strong-Buy” rating. The firm has “Hold” rating given on Tuesday, January 9 by Societe Generale. The stock has “Buy” rating by RBC Capital Markets on Friday, January 12. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Buy” rating by Bank of America on Friday, January 12. On Friday, January 12 the stock rating was maintained by BMO Capital Markets with “Hold”.

Since August 21, 2017, it had 1 insider purchase, and 10 sales for $23.24 million activity. 17,729 shares valued at $1.99M were sold by Friedman Stacey on Saturday, January 13. The insider Scher Peter sold 17,057 shares worth $1.91 million. Shares for $825,327 were bought by CROWN JAMES S on Tuesday, January 16. 65,101 shares were sold by Erdoes Mary E., worth $7.31 million on Saturday, January 13. Lake Marianne also sold $1.03 million worth of JPMorgan Chase & Co. (NYSE:JPM) shares. On Saturday, January 13 BACON ASHLEY sold $1.84 million worth of JPMorgan Chase & Co. (NYSE:JPM) or 16,434 shares.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.28, from 1.19 in 2017Q2. It is negative, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Hrt Finance Limited Liability invested in 0.44% or 3,755 shares. Crystal Rock Mgmt owns 106,927 shares. Lourd Cap Limited Company stated it has 0.08% in JPMorgan Chase & Co. (NYSE:JPM). Ls Invest Limited Co invested 0.76% in JPMorgan Chase & Co. (NYSE:JPM). 35,410 are owned by Rainier Invest Mgmt Lc. Horizon Kinetics Limited Liability Co holds 0.02% or 8,910 shares in its portfolio. First City Cap Management Incorporated has invested 1.22% in JPMorgan Chase & Co. (NYSE:JPM). Skylands Capital Limited Liability Company holds 113,500 shares or 1.44% of its portfolio. Legal And General Gru Public Ltd holds 1.3% in JPMorgan Chase & Co. (NYSE:JPM) or 18.08M shares. Country Club Trust Company Na holds 17,749 shares. D L Carlson Invest Gru Inc stated it has 77,864 shares or 2.31% of all its holdings. Dekabank Deutsche Girozentrale holds 1.40 million shares or 1.02% of its portfolio. Chilton Mngmt Lc holds 1.48% or 160,667 shares in its portfolio. Convergence Investment Prtn Ltd Liability Co has 1.86% invested in JPMorgan Chase & Co. (NYSE:JPM). Howe Rusling stated it has 2.07% in JPMorgan Chase & Co. (NYSE:JPM).

Sirios Capital Management L P, which manages about $2.06B and $1.91 billion US Long portfolio, upped its stake in Convergys Corp (NYSE:CVG) by 26,771 shares to 517,827 shares, valued at $13.41M in 2017Q3, according to the filing. It also increased its holding in Kar Auction Svcs Inc (NYSE:KAR) by 185,288 shares in the quarter, for a total of 607,607 shares, and has risen its stake in Nuance Communications Inc (NASDAQ:NUAN).

Among 6 analysts covering Aldeyra Therapeutics Inc (NASDAQ:ALDX), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aldeyra Therapeutics Inc had 13 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, September 26 by H.C. Wainwright. H.C. Wainwright maintained Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) rating on Wednesday, August 9. H.C. Wainwright has “Buy” rating and $1800 target. Cantor Fitzgerald maintained Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) rating on Thursday, November 9. Cantor Fitzgerald has “Buy” rating and $22.0 target. The stock of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has “Buy” rating given on Wednesday, August 9 by Cowen & Co. The stock of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) earned “Buy” rating by H.C. Wainwright on Thursday, June 15. On Wednesday, June 14 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm has “Buy” rating by Cantor Fitzgerald given on Tuesday, October 24. On Wednesday, September 13 the stock rating was maintained by Canaccord Genuity with “Buy”. Cowen & Co initiated Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) rating on Tuesday, September 8. Cowen & Co has “Outperform” rating and $15 target. The rating was initiated by Stifel Nicolaus on Friday, July 1 with “Buy”.

683 Capital Management Llc, which manages about $566.08 million and $951.63M US Long portfolio, decreased its stake in Etsy Inc by 210,000 shares to 750,000 shares, valued at $12.66 million in 2017Q3, according to the filing. It also reduced its holding in Peabody Energy Corp New by 116,960 shares in the quarter, leaving it with 269,400 shares, and cut its stake in Uniqure Nv (NASDAQ:QURE).

Since September 19, 2017, it had 1 buying transaction, and 0 selling transactions for $1.45 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Henry Gaston

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: